Abstract
Introduction
The application of p -values -and null hypothesis significance testing in general -remains a controversial topic in many appliedstatisticalfields,includingbiostatistics.Thecurrently mostwidelyused(frequentist)apparatusofbiostatisticsdoesnot -as readers, clinical researchers and sometimes even textbooks seem to believe -represent a straightforward logical construct, but rather an incompatible hybrid of the Fisherian andtheNeyman-Pearsontradition [1] [2] [3] [4] ,whichisitselfproblematic, and an application and interpretation routine that is oftendeeplyflawed.Themostimportanttypicalerrors,fallacies, misunderstandings and misuses include [5] [6] [7] [8] [9] [10] [11] :
• Confusingclinicalsignificance(whethertheeffectsizeis meaningful in the domain, in this case, medically) with statisticalsignificance(whethertheeffectisassumedtobe largerthanwhatcanbeattributedtosamplingvariation).
• Application of the apparatus in non-sampling situations orforextremelylargesamples.
• Forgetting that p-values and the related inferential apparatusonlycapturesamplingerror,butsaynothingofthe potentialnon-samplingsourcesoferror(i.e.biases).
• Forgetting whether the null hypothesis is -medicallymeaningfulatallornot(especiallypointnulls).
• Assuming that p-valueisanerrorprobability,i.e.theprobabilitythatthenullhypothesisistrue,giventhesample.
Manybelievethattheseerrorsaremajorcontributorstothe "replicabilitycrisis"thatisoftendiscussednowadaysinmedicine [12, 13] .
These problems are so profound, despite that so prevalent [14] , that there have been memorable attempts which implemented the most radical solution: banning the apparatus completely or almost completely. Perhaps most notable is the case of the Epidemiology journal [15] (with the rather strict policy removed in 2001 when founding editor Kenneth Rothman stepped down [16] ) and the more recent example of the journal Basic andApplied Social Psychology [17] .These decisions, in particular the question whether they are effective or needed, led to a widespread controversy, with American 
where  symbolizesthesample.( P meanseitherprobabilityor density(i.e.likelihood),dependingonwhetherthevariableis discreteorcontinuous.)Onecannowimmediatelyseethatwe
, that is, the prior probability of the null hypothesis toobtaintheprobabilitythatisthoughtbymanytobegivenby the p -value.(Forgettingthisisidenticaltothebaseratefallacy.) Itseffectcanbedramatic:itisquiteeasytoseethatinthemost simple situation, a p -valueof 0.05 mightverywellmean36% probability that the null is true (no effect found) if the prior probabilityisonly10% [19, 20] . Outofthese,perhapstheBayesFactorsarethe-relatively -most well-known.The basic idea is rather simple: take the sameequationas(1)butfor H 1 (instead of H 0 ), and divide the two;thusweobtain
as the term P (  ) fortunately cancels. Noting that P ( H 1 ) = 1−P ( H 0 ) (and likewise for the conditional probability) we actually have
butaprobabilitydividedbyoneminusthatprobabilityisodds, so we can write
The remaining factor on the right-hand side is called Bayes Factor [23, 24] :
.
In other words, this is the factor with which we have to multiply the prior odds to obtain the posterior odds.
In practice, if the two hypotheses represent restrictions on a -not necessarily one-dimensional -parameter θ , i.e.
where π ( ϑ ) is the prior distribution of the parameter. This is similar to the likelihood-ratio that is very well-known in frequentiststatisticstoo,butinsteadofthesupremumofthelikelihoodbeingtaken,practicallyaweightedaverageisformed, weightedbytheprior.
This definition can be substantially simplified in the practically very important scenario of the null hypothesis being a point null (i.e. θ = (ξ, η) , where dim ξ = 1 with H 0 : ξ = ξ 0 and H 1 : ξ ≠ ξ 0 , thus η represents the nuisance parameters). If we assume that the prior for ξ is continuous at ξ 0 (conditional on the nuisance parameters) then the numerator can
, and by Bayes' theorem we have
.Asthedenominatoris
inthiscase.ThisiscalledtheSavage-Dickeydensityratio [25] . AcharacteristicofBayesFactorsistheneedforpriorinformation on the investigated parameter's distribution. This is generally true for Bayesian methods; whether it is a drawbackornot,andhowthepriorshouldbeselectedisamatter ofvast,decade-longdebate [26, 27] .Alternatively,somehave proposedtheusageoftheso-called"MinimumBayesFactor", i.e. the smallest Bayes Factor that is possible (over all priors) [28, 29, 30] ,whichisthereforenolongerdependentonthe prior(butmaybedependentoncertainassumptions).And,of course,onehastobewillingtoacceptthefactthatthismetric is no longer a "context independent" measure, but rather the priorbeliefisneededtobeincorporatedlateron(whichisjust anadvantage,i.e.thatBayesFactorsmakethisfactexplicit).
As Bayes Factor has many further advantages, and corrects many misuses that are often apparent with p -values, its
wider application been endorsed by Goodman [31, 32] and Wagenmakers [33] ,amongothers.
Despite this, Bayes Factors are seldom used in practice in medicine, especially in "ordinary" clinical papers -their appearanceismostlylimitedtopapersthatspecificallydemonstrateorinvestigatetheirusefulness(e.g. [34] ),buttheyalmost never appear as regular apparatus in the investigation of usual clinicalquestions.
Theaimofthispaperisinvestigatethereal-lifeapplicability of Bayes Factors by comparing the results obtained with themtothatofnullhypothesissignificancetestinginasimple,butrealisticmedicalscenarioonindividualpatientdata. The paperwill be purely descriptive, i.e. no in-depth attempt is made to give theoretical (mathematical) explanation to the observedphenomena.
Material and Methods

Investigated questions
The aim will be to investigate the applicability of Bayes Factors in regression analysis with -standard, normal -linear modelsbycomparingthemtotraditionalmeans(i.e. p -values). Itwasselectedasanexamplebecauseregressionanalysisisone ofthemostfundamentaltoolsinbiostatistics,thusthiswillbe arelevantexample.However,asapreliminaryinvestigation,it willbeconfinedtothemostsimplequestionwithinregression analysis: assessing a single explanatory variable's impact (in itself)ontheresponsevariable.(Althoughthisshouldbedone withcautionwhenmulticollinearityispresent,butisneverthelessaverybasicanalyticalquestion.)
Within the null hypothesis significance testing framework, thisquestioncanbeaddressedbythe t -test, as discussed in any standardtextbook [35, 36] .TheBayesFactorsapproachinits most popular form for this case [37, 38] will be now briefly outlined.
Consider the following regression model:
where ε i isassumedtobeindependentnormalvariatewithzero mean and constant σ variance. Our research question can be formulated as H 0 :
where ϕ is the standard normal density.Assuming we know every regression coefficient apart from β j and the error variance σ (theseassumptionscanberelaxed,orwecanconsider the analysis to be conditional on them) all we need is pi ( b ) , the prior distribution of a regression coefficient. The most popular choice is Cauchy-distribution, which is equivalent to ahierarchicalnormal/inversegammamodel(butthislattercan bemoreeasilygeneralizedtothismultivariatecase):
n,p and s is a new (hyper)
parameter. This choice is usually called weekly informative, fulfilling location and scale invariance, consistency and consistencyininformation(objectiveordefaultprior).Thisis usuallyattributedtoJeffreys,withanexpansionfromZellner andSiow(JZSprior) [23, 39] . Now that the methods are clarifed, the questions of interest willbemorespecifically:
• HowBayesFactorscompareto p -values?
• Howisthisrelationshipaffectedbycertainparameters, particularly the applied prior ( s )andthesamplesize?
Patient data
To present a realistic example, real-life data from the representativeUSsurveyNationalHealthandNutritionExamination Survey(NHANES)willbeused.NHANESisnowacontinuouspublichealthprogram,withresultspublishedinbiannual cycles [40] . It is a nation-wide survey aimed to be representativeforthewholeciviliannon-institutionalizedUSpopulation,byemployingacomplex,stratifiedmulti-stageprobabilitysamplingplan.Theamountofcollecteddataistremendous (although sometimes varying from cycle to cycle), including demographic data, physical examination, collection of clinical chemistry parameters, and a thorough questionnaire concentratingonanamnesisandlifestyle.Now p = 43 clinical chemistry parameters 1 fromthe2013/14cycle-themostrecentavailable -willbeused [41] .Tomakethedatabasemorehomogeneous, it was filtered to males aged 18 years or more. For simplicity, subjects with any missing value were left out.Although forpreciseanalysesitisimportanttotakethesurveystructure into account by weight, now -as the focus of the study was elsewhere-thiswasneglectedforsimplicity.
Onthisdatabase,regressionscanbecarriedoutbyregressingoneofthesevariablesagainsttherest.Theseareclinically meaningfulandbasedonreal-lifedata.Aswehaveanumber ofvariables,thisdatabasealsomakesitpossibletoinvestigate regressions of very different nature (as variables have a very diversedistribution,andcorrelationalstructure).
Thefinalsamplesizewas n = 1190 ;thisislargeenoughso thatsubsamplescanbealsousedwhenstudyingsmallersamples(withhavingresultsforthefullsample). 
Programs used
All analysis was carried out under the R statistical program package, version 3.3.1 [42] with a custom script developed for this purpose that is available at the corresponding author on request. The Bayes Factors were calculated with package BayesFactor, version 0.9.12-2 [43] . Data visualization is performed with the latticepackage,version0.20-33 [44] .
Results
A comparison of the p -valuesandBayesFactorsofthepredictorvariablesinaregressionisshownonFig.1fortheexam-pleofglycohemoglobin.
Therelationshipisalmostperfectlylinearbetweenthelogarithm of the p -valueandtheBayesFactor.Thisisnoexception: Fig.2showsthesamescatterplotsforallvariables (allvariable selected as response, one at a time, and the remaning being predictors)inlogaritmicscale.Indeed,eventhesmallestlinear correlationcoefficientbetweenthelogarithmsisover 0.99 .
Next,theroleofthesamplesizewillbeinvestigated.The sameanalysisasonFig.1wasrepeated,butwithsmallersamples.Thesewererandomlysampledfromthewholedatabase (with replacement); sample sizes 50, 100, 200 and 500 were used. Actually, the aim of this investigation is twofold: this methodmakesitpossiblenotonlytoinvestigatetheeffectof samplesize,butalsothesamplingvariationasnowmanysamples could be investigated. (1000 random samples were now drawn.) Results are shown for the example of serum glucose (asexplanatoryvariable): Fig.3showstheunivariatedistribu-tions,Fig.4showsthejointsdistribution .
Onecanseethatboth p -valuesandBayesFactorsgetsmaller assamplesizeincreases(logically),andalsotheirvariability decreases(notethelogarithmicscale).
The joint distribution reveals that the relationship between p -values and Bayes Factors gets stronger with increasing sample size.(Thusitisnosurprisethatwehaveseenanalmostperfectrelationshipforthewholesample.)Again,notetheshiftingtolower p -value/BayesFactor with increasingsamplesize, as expected. Theotherobservationthatisveryclearfromthescattergramis the strong relationship in this sense too, and -more importantlyitisnowapparentthatthisgetsstrongerwithsamplesize.
Finally, the effect of the used prior was investigated. As it was already discussed, "used prior" now means the selection of the s hyperparameter; in addition to the default √ __ 2 / 4 ("medium", this was used everywhere up to here), the alternatives 1 / 2 ("wide")and √ __ 2 / 2 ("ultrawide")werenowinvestigated.ResultsareshownonFig.5(againfortheexampleof glycohemoglobin).Onecanseethatthepatternissimilar,with the points shifted upwards as the value of s increases;thisis againlogical.
Discussion and conclusion
p -valuesandBayesFactorsarestronglyrelated.Theirrelationship comes as no surprise as they measure related characteristics;thestrengthoftheconnectioniswhatcanbesurprisingatfirstglance.
However, it should be noted that in simple cases it might even happen that there is a deterministicrelationshipbetween thetwo [45] .Evenwhennot,suchstrongrelationshiphasbeen alreadydescribedintheliterature [46, 47] .Thereasoncanbe bestseenforpointnullhypotheses(asinthepresentcase)by consideringtheSavage-DickeyratiopresentedinEq. (7):the BFistheratiooftwodensitiesunderthesamemodel,while p -value is related to the posterior density, and they are changing roughly proportionally when S ischanging [48] . Thepresentresearchalsomakesitclearthat-intheinvestigated scenario -the relationship gets stronger with increasing samplesize:forsampleslargerthanafewhundredobservation, therelationshipisalmostperfect.
WhenusingJZSprior,thechoiceofthe s parameter had no majorimpactontherelationshipbetween p -valuesandBayes Factors,butuniformlyshiftedBayesfactors.
Finally,itisimportanttoemphasizethatthesefindingsdo notmakeBayesFactorspointless:evenforaperfectrelationship,themessageconveyedbyBayesFactorsisdifferent(and, aswehaveseen,muchmoreinstructiveandscientificallycorrect thanthe current typical practice with p -values). 
